Jane Myles, VP Innovation at Curebase

Note to File

Our guest this week is Jane Myles (with an occasional guest appearance by her canine friend). Jane is a self-proclaimed clinical trial operations nerd. She’s had the opportunity to work on global drug development programs across many therapeutic areas but calls Hematology/Oncology her TA home base. Jane switched from molecule focus to portfolio focus about 12 years ago, first focused on patient recruitment, then patient voice and input, then patient facing technology and it's adoption. She’s able to merge them all together in her current role as VP Innovation at Curebase, building DCT technology and services to drive access and inclusion to trials.

In this episode we discuss the tall order of standardizing definitions in decentralized clinical trials, the role of sites in technology adoption, Jane’s role with DTRA, lessons learned from the beach, and so much more.